Risperidone use in Korean patients with Alzheimer's disease: Optimal dosage and effect on behavioural and psychological symptoms, cognitive function and activities of daily living

Human Psychopharmacology

Volumn 18, Issue 8, 2003, Pages 627-633

  Yoon, Jin Sang ^a   Kim, Jae Min ^b   Lee, Hoon ^c   Shin, Il Seon ^a   Choi, Sung Ku ^d  

^a Chonnam National University Medical School   (South Korea)

^b Chosun University   (South Korea)

^c Department of Old Age Psychiatry   (South Korea)

^d Janssen Korea   (South Korea)

Author keywords

ADL; Alzheimer disease; BPSD; Cognitive function; Dementia; Risperidone

Indexed keywords

CHOLINESTERASE INHIBITOR; HYPNOTIC AGENT; RISPERIDONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DISEASE SEVERITY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; KOREA; MALE; MENTAL DISEASE; MENTAL FUNCTION; MENTAL HEALTH; NEUROLOGIC DISEASE; OPEN STUDY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RATING SCALE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; ANTIPSYCHOTIC AGENTS; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PROSPECTIVE STUDIES; RISPERIDONE; TREATMENT OUTCOME;

EID: 0346339680     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.543     Document Type: Article

References (27)

1. American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. American Psychiatric Association: Washington, DC.
2. Bhana N, Spencer CM. 2000. Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia. Drugs Aging 16: 451-471.
3. Chan WC, Lam LC, Choy CN, Leung VP, Li SW, Chiu HF. 2001. A double-blind randomized comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients. Int J Geriatr Psychiatry 16: 1156-1162.
4. Condren RM, Cooney C. 2001. Use of drugs by Old Age Psychiatrists in the treatment of psychotic and behavioural symptoms in patients with dementia. Aging Ment Health 5: 235-241.
5. De Deyn PP, Rabheru K, Rasmussen A, et al. 1999. A randomized trial of risperidone, placebo and haloperidol for behavioural symptoms of dementia. Neurology 22: 946-955.
6. Defilippi JL, Crismon ML. 2000. Antipsychotic agents in patients with dementia. Pharmacotherapy 20: 23-33.
7. Donaldson C, Tarrier N, Burns A. 1998. Determinants of carer stress in Alzheimer's disease. Int J Geriatr Psychiatry 13: 248-256.
8. Edell WS, Tunis SL. 2001. Antipsychotic treatment of behavioural and psychological symptoms of dementia in geropsychiatric inpatients. Am J Geriatr Psychiatry 9: 289-297.
9. Haupt M, Kurz A. 1993. Predictors of nursing home placement in patients with Alzheimer's disease. Int J Geriatr Psychiatry 8: 741-746.
10. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. 1999. Comparison of risperidone and placebo for psychosis and behavioural disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 60: 107-115.
11. Kim J-M, Shin I-S, Jeong S-J, Gormley N, Yoon J-S. 2002. Predictors of institutionalization in patients with dementia in Korea. Int J Geriatr Psychiatry 17: 101-106.
12. Kim Y-D, Kim D-H, Lee C-H, Kim D-H. 2001. The effect of risperidone on controlling behavioural and psychological symptoms of dementia. J Korean Geriatr Soc 5: 250-264.
13. Kopala LC, Honer WG. 1997. The use of risperidone in severely demented patients with persistent vocalizations. Int J Geriatr Psychiatry 12: 73-77.
14. Lane HY, Chang YC, Su MH, Chiu CC, Huang MC, Chang WH. 2002. Shifting from haloperidol to risperidone for behavioural disturbances in dementia: safety, response predictors and mood effects. J Clin Psychopharmacol 22: 4-10.
15. Lingjaerde O, Ahlfors UG, Bech P, et al. 1987. The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic treated patients. Acta Psychiatr Scand S76: 1-100.
16. Masand PS. 2000. Side effects of antipsychotics in the elderly. J Clin Psychiatry 61 S8: 43-49.
17. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944.
18. Morris JC, Cyrus PA, Orazem J, et al. 1998. Metrifonate benefits cognitive, behavioural and global function in patients with Alzheimer's disease. Neurology 50: 1222-1230.
19. Park JH, Kwon YC. 1990. Modification of the mini-mental state examination for use in the elderly in a non-western society: Part I. Development of Korean version of Mini-Mental State Examination. Int J Geriatr Psychiatry 5: 381-387.
20. Park JH, Cho SW, Shon HS. 1995. Reliability of functional status measurements in elderly people. J Kr Neuropsychiatric Assoc 34: 475-483.
21. Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M. 2001. Effect of risperidone on behavioural and psychological symptoms and cognitive function in dementia. J Clin Psychiatry 62: 894-900.
22. Raskind MA, Sadowsky CH, Sigmund WR, Beitler PJ, Austen SB. 1997. Effect of tacrine on language, praxis and noncognitive behavioural problems in Alzheimer's disease. Arch Neurol 54: 836-840.
23. Reisberg B, Ferris SH, de Leon MJ, Crook T. 1982. The Global Deterioration Scale (GDS) for assessment of primary degenerative dementia. Am J Psychiatry 139: 1136-1139.
24. Stoppe G, Brandt CA, Staedt JH. 1999. Behavioural problems associated with dementia: the role of newer antipsychotics. Drugs Aging 14: 41-54.
25. Sub G-H, Son H-G, Shin H, et al. 2001. Reliability and analysis of symptom category scores of the Behaviour Pathology in Alzheimer's Disease Rating Scale, Korean version (BEHAVE-AD-K). J Korean Geriatr Psychiatry 5: 50-57.
26. Tariot PN. 1996. Treatment strategies for agitation and psychosis in dementia. J Clin Psychiatry 57 S14: 21-29.
27. Yoon J-S, Kim J-M, Lee H, Shin I-S, Lee Y-H, Lee H-Y. 2003. Effects of donepezil on behavioural and psychological symptoms in patients with Alzheimer's disease. Korean J Psychopharmacol 14: 129-137.